The Multifunction Of miR-218-5p-Cx43 Axis In Breast Cancer

BACKGROUND: Gemcitabine is proven to be the first-line standard treatment of breast cancers. Yet, little is known involving gemcitabine resistance and remains largely to be elucidated. MATERIALS AND METHODS: We evaluated the expression of Cx43 in gemcitabine-resistant cells and parental cells by qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Chen, Jiang, Hong, Ye, Fugui, Zhuang, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790128/
https://www.ncbi.nlm.nih.gov/pubmed/31632081
http://dx.doi.org/10.2147/OTT.S218524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790128/
https://www.ncbi.nlm.nih.gov/pubmed/31632081
http://dx.doi.org/10.2147/OTT.S218524

Ejemplares similares